On February 28, 2023 Coherus BioSciences, Inc. ("Coherus", Nasdaq: CHRS) reported that its fourth quarter and full year 2022 financial results will be released after market close on Monday, March 6, 2023 (Press release, Coherus Biosciences, FEB 28, 2023, View Source/news-releases/news-release-details/coherus-biosciences-report-fourth-quarter-and-full-year-2022" target="_blank" title="View Source/news-releases/news-release-details/coherus-biosciences-report-fourth-quarter-and-full-year-2022" rel="nofollow">View Source [SID1234627836]). Starting at 5:00 pm ET on March 6, 2023, Coherus’ management team will host a conference call and webcast to discuss financial results and provide a general business update.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
A replay of the webcast will be available on View Source following the conclusion of the live conference call.
Conference Call Information
When: Monday, March 6th, 2023, starting at 5:00 p.m. Eastern Time
To access the conference call, please pre-register through the following link to receive dial-in information and a personal PIN to access the live call: https://register.vevent.com/register/BI8a3cc318d81c4ebaa9d8f6e635f9731c
Webcast: View Source
The press release with the fourth quarter and full year 2022 financial results and related materials will be available at View Source prior to the start of the conference call.
A live and archived webcast will be available on the "Investors" section of the Coherus website at View Source.
Please dial-in 15 minutes early to ensure a timely connection to the call.